AMM4739-11
[Monoclonal Antibody]
NEDD9 Mouse Monoclonal Antibody
www.yhsbio.com
market@yhsbio.com
support@yhsbio.com
+86-21-54651191
Room 703,Building 6,333# Guiping
Rd.,Xuhui District,Shanghai,China
DATASHEET
Species: |
Mouse |
Applications: |
WB ELISA |
Immunogen Range: |
NEDD9 (NP_006394, 101 aa ~ 200 aa) partial recombinant protein with GST tag |
Clonality: |
Monoclonal Antibody |
Isotype: |
IgG1 Kappa |
GENE ID: |
4739 |
Swiss Prot: |
Q14511 |
Synonyms: |
CAS-L, CAS2, CASL, CASS2, HEF1, dJ49G10.2, dJ761I2.1 |
Purification: |
Affinity purification |
Storage: |
Store at -20°C or lower in ascites fluid. Avoid freeze/thaw cycles. |
Background: |
Human enhancer of filamentation protein 1 (HEF1), also known as neural precursor cell expressed developmentally down-regulated protein 9 (NEDD9), is part of the Cas family of proteins, which include HEF1/NEDD9, p130Cas and Efs. HEF1 is a predominantly cytoplasmic protein, localizing to focal adhesions during interphase, and centrosomes and other parts of the mitotic apparatus during G2/M phase of the cell cycle. HEF1 is a docking protein that plays a central coordinating role for tyrosine kinase-based signaling related to cell adhesion, motility, growth and apoptosis. Phosphorylation of HEF1 is induced by a number of factors, including FAK, TGF-β, PDGFR, Abl, and BCR-ABL, which leads to coordinate binding of multiple downstream effector proteins via 15 known SH2 domain-binding sites. HEF1 is a key regulator of cancer metastasis. It is required for the invasive activity of glioblastomas, is linked to the promotion of metastasis in melanoma, and is found to be up-regulated in lung cancer metastasis. |
Caculated MW: |
105, 115 kDa |
Observed MW: |
Refer to Figures |
Applications: |
|
Reacitivity: |
Human |
For research use only. Not intended for diagnostic or therapeutic use!